|
UNK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63424829224823E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.63913368725844E-14 |
| Normal-vs-Stage2 |
1.216950E-04 |
| Normal-vs-Stage3 |
3.31956684362922E-14 |
| Normal-vs-Stage4 |
1.64845914696343E-12 |
| Stage1-vs-Stage2 |
1.108990E-01 |
| Stage1-vs-Stage3 |
2.899600E-01 |
| Stage1-vs-Stage4 |
3.239700E-02 |
| Stage2-vs-Stage3 |
4.829600E-02 |
| Stage2-vs-Stage4 |
9.041700E-03 |
| Stage3-vs-Stage4 |
2.836000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.10622663543836E-15 |
| Normal-vs-AfricanAmerican |
1.81994999999269E-05 |
| Normal-vs-Asian |
2.98770008733129E-10 |
| Caucasian-vs-AfricanAmerican |
4.006200E-01 |
| Caucasian-vs-Asian |
4.440800E-01 |
| AfricanAmerican-vs-Asian |
6.656000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.10513853413386E-12 |
| Normal-vs-Female |
1.63502544836547E-12 |
| Male-vs-Female |
8.558000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63924429585904E-12 |
| Normal-vs-Age(41-60Yrs) |
5.75761660570606E-13 |
| Normal-vs-Age(61-80Yrs) |
1.81080039851622E-10 |
| Normal-vs-Age(81-100Yrs) |
1.85192999999639E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.786600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.098400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.734000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.871400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.285200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.906200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.59239999997229E-06 |
| Classical-VS-Follicular |
8.119200E-01 |
| Classical-VS-Other |
7.017800E-01 |
| Classical-VS-Normal |
1.65312208366686E-12 |
| Tall-VS-Follicular |
5.994700E-04 |
| Tall-VS-Other |
3.477000E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
7.461000E-01 |
| Follicular-VS-Normal |
1.15199999983773E-07 |
| Other-VS-Normal |
1.363860E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.20679030604742E-12 |
| Normal-vs-N1 |
5.43619593784683E-11 |
| N0-vs-N1 |
1.739810E-01 |
|
|
